trump rx glp-1 Weight-loss drug makers announce pricing agreement with President Trump Launches TrumpRx.gov, Delivering

The key question isn't whether these medications are compatible with thyroid diseaseit's how to use them safely with proper medical supervision

At 48 weeks, 64 to 100% of participants in the retatrutide groups had body-weight reductions of 5% or more, as compared with 27% of the participants in the placebo group

That fiber deficit represents a massive missed opportunity for natural GLP-1 support

A 2024 study published in Proceedings of the National Academy of Sciences estimates that GLP-1s can prevent more than 42,000 deaths each year, including 11,000 deaths among people with type 2 diabetes

Here is what has changed and why it matters

Despite the possibility of adverse events, GLP-1 RAs continue to represent a crucial therapeutic modality for metabolic disturbances